Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Sterol Carrier Protein 2 (SCP2) (N-Term) Peptide

SCP2 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN2182307

Aperçu rapide pour Sterol Carrier Protein 2 (SCP2) (N-Term) Peptide (ABIN2182307)

Antigène

SCP2 (Sterol Carrier Protein 2 (SCP2))

Origine

Humain

Source

  • 5
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Séquence

    SSPWEPATLR RVFVVGVGMT KFVKPGAENS RDYPDLAEEA GKKALADAQI

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-SCP2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Conseil sur la manipulation

    Avoid repeat freeze-thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    SCP2 (Sterol Carrier Protein 2 (SCP2))

    Sujet

    SCP2 protein is thought to be an intracellular lipid transfer protein. SCP2 is highly expressed in organs involved in lipid metabolism, and may play a role in Zellweger syndrome, in which cells are deficient in peroxisomes and have impaired bile acid synthesis.

    Alias Symbols: NLTP, NSL-TP, SCP-2, SCP-CHI, SCP-X, SCPX

    Protein Size: 503

    Poids moléculaire

    55 kDa

    ID gène

    6342

    NCBI Accession

    NM_001193600, NP_001180529

    UniProt

    A6NM69
Vous êtes ici:
Chat with us!